Trajan Group Holdings Limited (ASX:TRJ)

Market Cap	102.96M
Revenue (ttm)	166.46M
Net Income (ttm)	-4.46M
Shares Out	152.54M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	22.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,492
Average Volume	48,739
Open	0.6750
Previous Close	0.6750
Day's Range	0.6650 - 0.6750
52-Week Range	0.6250 - 1.1400
Beta	0.51
RSI	49.77
Earnings Date	Feb 26, 2026

About Trajan Group Holdings

Trajan Group Holdings Limited develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, inlet liners, rings, and tubing products; and sampling products, comprising septa, caps, liners, well plates and sealing mats, crimping tools, and micro sampling tools, as well as automation systems and consumables. It also provides pathology produ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Employees: 650
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRJ

Financial Performance

In 2025, Trajan Group Holdings's revenue was 166.46 million, an increase of 7.38% compared to the previous year's 155.02 million. Losses were -4.46 million, -82.39% less than in 2024.